Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-02-11

FDA Approved: ZOLMITRIPTAN OD — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application to authorize Zolmitriptan Oral Disintegrating Tablet (OD) for acute treatment of migraine, manufactured by Jubilant Cadi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zolmitriptan OD (Zolmitriptan)

Snippet

SUPPL AP for ZOLMITRIPTAN OD (ZOLMITRIPTAN)